Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $33.33 USD
Change Today -0.10 / -0.30%
Volume 876.9K
ACOR On Other Exchanges
As of 7:40 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John P. Kelley MBA

Director, Chairman of Compensation Committee and Member of Ad Hoc Business Development Committee, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 2 different organizations across 4 different industries.

See Board Relationships


Mr. John P. Kelley, MBA co-founded Phyxius Pharma, Inc. in 2011 and serves as its Chief Executive Officer. Mr. Kelley has been the Chief Executive Officer of Tenax Therapeutics, Inc. since November 14, 2013. He served as the President and Chief Operating Officer of The Medicines Co. from December 2, 2004 to October 1, 2009. Mr. Kelley started his tenure at the Medicines Company from Aventis Pharmaceuticals, Inc., with close to 37 years of experience in the pharmaceutical ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

Former President, Chief Operating Officer and Director
Director, Chairman of Compensation Committee and Member of Ad Hoc Business Development Committee
Chief Executive Officer and Director


Rockhurst University
Wilkes University
Wilkes University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$151,250

Stock Options*

Exercisable Options446,110
Unexercisable Options446,110
Total Number of Options892,220

Total Compensation*

Total Annual Cash Compensation$233,750
Total Short Term Compensation$151,250
Total Calculated Compensation$4,188,378
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $33.33 USD -0.10


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at